首页> 外文期刊>International Journal of Biosciences >Antimalarial potential of leaves crude extract of Monotheca buxifolia
【24h】

Antimalarial potential of leaves crude extract of Monotheca buxifolia

机译:麒麟菜叶粗提液的抗疟潜力

获取原文
           

摘要

The human’s malarial infection is transmitted mainly by Plasmodium vivax and Plasmodium falciparum where the most usual cause of malarial infection is Plasmodium vivax which is about 80% of all malarial cases and 10% of the deaths. So the present study was focused on the effects of methanolic crude extract of Monotheca buxifolia leaves at the concentration 200 μg/ml against Plasmodium falciparum and Plasmodium vivax present in human blood samples. The blood samples (n=100) were collected from both the genders of various ages from six union councils namely, Uster Zai, Dhoda, Khormato, Jerma, Bilitang and Chickar Kot of district Kohat. Out of 100 patients, 4 patients were infected by Plasmodium falciparum (male=3, female=1) and 96 were infected by Plasmodium vivax (male=70, female=26). Maximum inhibition (80%) in the growth of Plasmodium falciparum was exhibited by methanolic fraction at the age groups of 6-15, 16-30 and 31-50 years male and female malarial patients. While, in the case of Plasmodium vivax, maximum percentage inhibition was exhibited by methanolic fraction (male=80%, female=82%) at the age group of 31-50 years. The Resochine (40 μg/ml) was used as positive control exhibited 100% inhibition of malarial parasites. Moreover, distilled water was used as negative control (200μl/ml) caused no effect.
机译:人类的疟疾感染主要通过间日疟原虫和恶性疟原虫传播,其中疟疾最常见的病因是间日疟原虫,约占所有疟疾病例的80%和死亡的10%。因此,本研究着眼于浓度为200μg/ ml的小叶monotheca甲醇粗提取物对人血液样本中的恶性疟原虫和间日疟原虫的影响。血液样本(n = 100)是从六个工会委员会的不同年龄的男女那里采集的,这些委员会分别是Kohat地区的Uster Zai,Dhoda,Khormato,Jerma,Bilitang和Chickar Kot。在100例患者中,有4例被恶性疟原虫感染(男性= 3,女性= 1),有96例受到间日疟原虫感染(男性= 70,女性= 26)。男性和女性疟疾患者在6-15岁,16-30岁和31-50岁年龄组中,甲醇分数显示出恶性疟原虫生长的最大抑制作用(80%)。而对于间日疟原虫,在31-50岁年龄组中,甲醇分数(男性= 80%,女性= 82%)表现出最大的抑制百分比。将Resochine(40μg/ ml)用作阳性对照,表现出100%的疟原虫抑制作用。而且,蒸馏水用作阴性对照(200μl/ ml)没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号